The two presumed calmodulin antagonists calmidazolium and compound 48/80 were compared for their effects on several calmodulin-dependent and calmodulin-independent enzyme systems. Compound 48/80 and calmidazolium were found to be about equipotent in antagonizing the calmodulin-dependent fraction of brain phosphodiesterase and erythrocyte Ca2+-transporting ATPase. Compound 48/80 combines high potency with high specificity in that: (1) the basal, calmodulin-independent, activity of calmodulin-regulated enzymes was not suppressed; (2) calmodulin-independent enzyme activities, such as Ca2+-transporting ATPases of sarcoplasmic reticulum, Mg2+-dependent ATPases of different tissues and Na+/K+-transporting ATPase of cardiac sarcolemma, were far less altered, or not altered at all, by compound 48/80 as compared with calmidazolium; and (3) antagonism of proteolysis-induced stimulation as opposed to calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase required a 32 times higher concentration of compound 48/80. In all these aspects compound 48/80 was found to be a superior antagonist to calmidazolium since inhibition of calmodulin-independent events by the other agent occurred at considerably lower concentrations. Therefore compound 48/80 is proposed to be a much more specific and useful tool for studying the participation of calmodulin in biological processes than the presently used agents.
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Calmodulin, the ubiquitous Ca2+-dependent regulatory protein, plays a pivotal role in all eukaryotic cells. It confers Ca2+_sensitivity on a multitude of enzyme systems and cell functions. Its properties and functions have been summarized in recent reviews (Cheung, 1980; Klee et al., 1980; Means & Dedman, 1980) .
The calmodulin-dependent fraction of these enzymes can be inhibited by a wide range of chemically unrelated substances, such as phenothiazines and butyrophenones (Levin & Weiss, 1976 ; , naphthalene sulphonamides (Kobayashi et al., 1979) , Vinca alkaloids , local anaesthetics (Volpi et al., 1981) , calmidazolium (Gietzen et al., 1981) , formerly referred to as R 24571, and compound 48/80 (Gietzen et al., 1983) . Several calmodulin inhibitors were also shown to antagonize the enzymes' activity stimulated bystreatments mimicking the action of calmodulin on phosphodiesterase and Ca2+-transporting ATPase (Wolff & Brostrom, 1976; Gietzen et al., 1982a) . In a recent study a general model has been proposed illustrating the molecular mechanism of Vol. 216 activation and inhibition of calmodulin-regulated enzymes simply by the assumption of hydrophobic and ionic interactions (Gietzen et al., 1982a) . Generally, activators of calmodulin-dependent enzymes (calmodulin, oleic acid or phosphatidylserine) can be considered as anionic amphiphiles, whereas calmodulin antagonists are cationic amphiphiles at physiological pH.
Evidence has been presented that inhibition of a calmodulin-stimulated enzyme may occur according to the following modes: (1) calmodulin is complexed by the cationic amphiphilic antagonist, as a result of their complementary structural features, via ionic and hydrophobic interactions (Weiss et al., 1980) ; and (2) in addition, several calmodulin antagonists exert their inhibitory effect via direct interaction with the calmodulin effector enzyme (Gietzen et al., 1982a,b) . Therefore, these substances cannot be considered as calmodulin-specific probes. Moreover, almost all described inhibitors are more or less unspecific in that they also inhibit the basal activity of calmodulin-dependent enzymes and even the activity of calmodulin-independent enzymes (Balzer et al., 1968 ; Levin & Weiss, 1976 ; Kobayashi et al., 1979; Gietzen et al., , 1981 Luthra, 1982) .
From the numerous calmodulin antagonists two were shown to be outstanding. (1) Calmidazolium was reported to be the most potent inhibitor (Gietzen et al., 1981; Van Belle, 1981) and in addition the substance displayed a higher specificity for calmodulin-induced activation of phosphodiesterase and Ca2+-transporting ATPase compared with other modes of stimulation (Gietzen et al., 1982a) . (2) Compound 48/80 was shown to be the most specific antagonist of calmodulin-dependent Ca2+-transporting ATPase activity as opposed to basal, calmodulin-independent, ATPase activity (Gietzen et al., 1983) .
In the present paper calmidazolium and compound 48/80 were compared directly under identical experimental conditions. The effects of both antagonists on several Ca2+-calmodulin-dependent, Ca2+-dependent but calmodulin-independent and Ca2+-calmodulin-independent enzymes were investigated. In nearly all respects, compound 48/80 proved to be superior to calmidazolium.
Materials and methods
All reagents were of the highest purity available. Calmidazolium was supplied by Janssen Pharmaceutica (Beerse, Belgium Homogeneous calmodulin was prepared from bovine brain as described by Kakiuchi et al. (1981) . Calmodulin-sensitive phosphodiesterase was partially purified, based on the method of Wang & Desai (1977) and slightly modified as described by Gietzen et al. (1982a) . Human erythrocyte membranes deficient in calmodulin were prepared by the procedure of Gietzen & Kolandt (1982) . Sarcoplasmic-reticulum vesicles were prepared from dog heart by the procedure of Suko & Hasselbach (1976) and from rabbit skeletal muscle by the procedure described by Meissner et al. (1973) . Vesicles of calf cardiac sarcolemma were purified as reported by Jones et al. (1979) and Caroni et al. (1980) .
Controlled tryptic digestion
Ca2+-transporting ATPase was digested at 37°C by 0.2mg of trypsin/mg of erythrocyte membrane protein. Proteolysis was performed in the assay medium and was terminated with a 5-fold excess (w/w) of trypsin inhibitor (see Gietzen et al., 1982a) .
Assay ofenzyme activities
ATPase and phosphodiesterase activities were determined at 370C by measuring the rate of P-liberation as reported by Stewart (1974) , slightly modified as described by Lanzetta et al. (1979) .
Briefly, phosphodiesterase activity was assayed by coupling the phosphodiesterase reaction with 5'-nucleotidase reaction (Butcher & Sutherland, 1962; Wang & Desai, 1977) and measuring the P1 produced within 30min. The assay mixture (final volume, 1 ml) consisted of 40 mM-Tris/HCl (pH 7.5), 40mM-imidazole, 3mM-magnesium acetate, 1.2mM-cyclic AMP and 0.1 mM-CaCl2.
The reaction of the different ATPases was followed discontinuously over various time periods depending on the specific activity of the respective enzyme. The assay medium for Ca2+-transporting ATPase contained, in a final incubation medium of 1 ml, 25 mM-4-morpholinepropanesulphonic acid (pH 7.0), 100mM-KCl, 0.25 mM-ouabain, 10mM-NaN3, 1 mM-ATP, 2mM-MgCl2 and a 0.2mM-Mg2+/ 0.2mM-Ca2+/0.4mM-EDTA buffer to yield a free Ca2+ concentration of 36pM (Wolf, 1973 Figs. 1(a) and 1(b). In the absence of the agents, as documented by the points on the ordinate (Fig. la) , Ca2+-transporting ATPase of disrupted erythrocyte membranes could be maximally stimulated by calmodulin 5-6-fold above the basal enzyme's activity ('basal' Ca2+-transporting ATPase activity was defined as that activity determined in the absence of added calmodulin). Phosphodiesterase displayed a somewhat higher sensitivity towards calmodulin in that calmodulin stimulated the enzyme in the absence of drugs 6.5-8-fold above its basal activity (Fig. lb) .
As can be seen from Fig. 1(a Table 1 . Effects ofcalmidazolium and compound 48/80 on diferent enzyme activities Enzyme activities were determined as described in the Materials and methods section at a concentration of 30,ug of protein/ml, except for the cases marked *, in which the protein concentration was 60,ug/ml. The IC50 values were obtained graphically from dose-effect curves. The coefficients of specificity represent the factors by which the inhibitors are more specific in antagonizing the calmodulin-dependent fraction of erythrocyte Ca2+-transporting ATPase activity as compared with the listed enzyme activities, or, vice versa, the numbers give the factors by which the inhibitor concentrations were found to be higher in order to achieve half-maximal inhibition of the respective enzyme activities as opposed to the calmodulin-dependent activity. Mg2+-dependent ATPases in the investigated concentration range (Table 1) .
The results of investigations to determine the potency of calmidazolium and compound 48/80 in antagonizing the stimulation of erythrocyte Ca2+-transporting ATPase induced by different activating treatments are shown in Table 1 . Half-maximal inhibition of the activity stimulated by oleic acid or mild tryptic digestion required 25 and 7 times higher concentrations of calmidazolium respectively, compared with the calmodulin-dependent fraction of the ATPase activity when assayed under identical conditions. Compound 48/80 shares with calmidazolium the property of antagonizing preferentially the calmodulin-induced stimulation of Ca2+-transporting ATPase. Half-maximal inhibition of the activating effects of calmodulin, oleic acid or limited proteolysis occurred at concentrations of 0.85, 7 and 27,ug of compound 48/80/ml respectively.
Discussion
In various studies evidence has been presented that putative calmodulin (Levin & Weiss, 1976; Kobayashi 1983 Kobayashi et al., 1979 Gietzen et al., , 1981 Gietzen et al., , 1983 . (2) Compound 48/80 altered calmodulin-independent Ca2+-transporting ATPases far less than calmidazolium (see Table 1 ) or phenothiazines (Balzer et al., 1968 (Table 1 ). In contrast, trifluoperazine and penfluridol were shown to be equipotent in antagonizing both the calmodulin-and proteolysis-stimulated activity of erythrocyte Ca2+-transporting ATPase (Gietzen et al., 1982a) .
Inhibition of basal activity of calmodulin-regulated enzymes and antagonism of the activity of calmodulin-independent enzymes by calmidazolium and other putative calmodulin antagonists, as mentioned in points (l)-(3) of the preceding paragraph, might be a direct effect on the target enzyme and/or a consequence of perturbation of the lipid environment in the case of membrane-integral enzymes (Raess & Vincenzi, 1980; Au, 1981; Luthra, 1982) . The high specificity of compound 48/80 may be determined by the polymeric structure of compound 48/80, as was suggested by Gietzen et al. (1983) . It was proposed that this structure may hinder incorporation of the agent into biological membranes and thus perturbation of the lipid environment of membrane-bound enzymes may be less favourable. In summary, it may be concluded that compound 48/80 is an outstanding calmodulin inhibitor in that this substance combines high potency and high specificity in antagonizing preferentially calmodulin-mediated enzyme activities. Therefore compound 48/80 is proposed to be a much more specific tool for studying the involvement of calmodulin in biological functions than the existing substances.
